Challenges and Solutions in the Era of GLP1s (Recorded Webinar)

Join us for an informative session designed to enhance your expertise in prescribing GLP1 medications for the treatment of obesity. This session will delve into the practical aspects of prescribing, navigating potential side effects, and overcoming accessibility challenges.

CME/CE Expiration Date: 7/29/27

*The expiration date listed above is the last day CME/CE credit can be claimed for this specificpresentation.

Learning Objectives

1. Learn how to prescribe GLP1 medications for obesity
2. Apply strategies to mitigate side effects and increase tolerability
3. Implement potential solutions to accessibility issues due to cost, coverage, or shortages 

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this Enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.
Course opens: 
07/29/2024
Course expires: 
07/29/2027
Cost:
$25.00

Bevery Tchang, MD, DABOM

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this Enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.

Price

Cost:
$25.00
Please login or register to take this course.

Required Hardware/software

For best user experience we recommend using a computer to attend this course.